[Algoneurodystrophy: treatment by betablockaders].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D011674:Pulse / Q000187:drug effects; D012019:Reflex Sympathetic Dystrophy / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists
Algoneurodystrophie: traitement par les bêtabloquants.